Zelluna – medical illustration

Mechanism of action illustration

Our medical illustration explaining the mechanism of action of CD4+ and CD9+ cells against tumour cells.

Client

Zelluna Immunotherapy is a Norwegian biotech company developing immunotherapy treatments against solid tumors using TCRs derived from CD4 and CD8 T cells.

Find out more on Zelluna’s website.